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SUMMARY: Conjugated linoleic acid (CLA) and conjugated linolenic acid (CLnA) have been known to have 
several health-promoting effects. The aim of this study was to introduce a novel structured lipid (SL) including 
both CLA and CLnA (cis9, trans11, cis13-18:3, punicic acid) into one triacylglycerol (TAG) molecule through 
enzymatic interesterification and investigate its effect on body weight, liver and serum lipids in Wistar rats. CLA 
oil, pomegranate seed oil (as a rich source of CLnA) and soybean oil (as a negative control) were applied as other 
experimental oils. The rats were fed the oils at 1500 mg/kg body weight per day via oral gavage for 45 days. Gas 
chromatography analysis showed that SL included CLnA and CLA in roughly equal concentrations. The in vivo 
study revealed that SL had the greatest effect on the reduction in liver lipid weight (4.65 g/100g of liver) and liver 
TAG (13.28 mg/g) compared to soybean oil (8.7 g/100g and 18.8 mg/g, respectively). High density lipoprotein cho-
lesterol (HDL-C) in the serum of rats which were fed CLA oil significantly (p < 0.05) increased (from 0.95 to 1.14 
mmol/l). Pomegranate seed oil reduced low density lipoprotein cholesterol (LDL-C) and total cholesterol (about 
40% and 24% reduction, respectively). A remarkable TAG reduction (p < 0.05) was observed in all treated rats.
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RESUMEN: Lípidos hepáticos y séricos en ratas Wistar alimentadas con nuevos lípidos estructurados que con-
tienen ácido linoleico conjugado y ácido linolénico conjugado. Se sabe que el ácido linoleico conjugado (CLA) y 
el ácido linolénico conjugado (CLnA) tienen varios efectos positivos para la salud. El objetivo de este estudio 
fue producir un nuevo lípido estructurado (SL) que incluye tanto CLA como CLnA (cis9, trans11, cis13-18:3, 
ácido púnico) en una molécula de triacilglicerol (TAG) a través de la interesterificación enzimática e investigar 
su efecto en el cuerpo, peso, lípidos hepáticos y séricos en ratas Wistar. El aceite de CLA, el aceite de semilla de 
granada (como una fuente rica de CLnA) y el aceite de soja (como control negativo) se aplicaron como otros 
aceites experimentales. Las ratas fueron alimentadas con los aceites a razón de 1500 mg/kg de peso corporal por 
día mediante sonda oral durante 45 días. El análisis por cromatografía de gases mostró que SL incluía CLnA y 
CLA en una concentración aproximadamente igual. El estudio in vivo reveló que SL tuvo el mayor efecto sobre 
la reducción del peso de lípidos hepáticos (4,65 g/100 g de hígado) y TAG hepático (13,28 mg/g) en comparación 
con el aceite de soja (8,7 g/100 g and 18,8 mg/g, respectivamente). El colesterol de lipoproteínas de alta densidad 
(HDL-C) en suero de ratas que fueron alimentadas con aceite de CLA significativamente (p <0.05) aumentó 
(de 0.95 a 1.14 mmol/l) y el aceite de semilla de granada podría reducir el colesterol de lipoproteínas de baja 
densidad (LDL-C) y colesterol total (aproximadamente 40% y 24% de reducción, respectivamente). Se observó 
una notable reducción de TAG (p <0.05) en todas las ratas tratadas.
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1. INTRODUCTION
The disturbance in carbohydrate and lipid 
metabolisms and their subsequent outcomes such 
as obesity, diabetes and cardiovascular disease are 
currently the main health problems worldwide. 
Increasing evidence indicates that functional lip-
ids, in addition to their nutritional roles, could have 
beneficial effects on the prevention and treatment 
of these metabolic disorders. Conjugated linoleic 
acid (CLA), conjugated linolenic acid (CLnA) and 
gamma linolenic acid are some of the mostly widely 
studied functional lipid components (Lee and Lee, 
2006; Rodríguez-Alcalá et al., 2017)
CLA is a general term referring to all positional 
and geometrical isomers of conjugated linoleic 
acid. The physiological impacts of CLA are mainly 
related to only two isomers of cis9, trans11 and 
trans10, cis12 CLA (Gnadig et al., 2003; Park, 2009). 
It needs to be pointed out that naturally occurring 
CLA, present in foods such as meat, milk, and dairy 
products, mainly consists of the cis9, trans11 iso-
mer (> 80%) (Park, 2009). In 1995, the first report 
regarding the ability of CLA to reduce the body fat 
of mice was published (Park et al., 1995). This work 
exhibited that the addition of 5% CLA to dietary 
food significantly reduced the animal’s body lip-
ids and increased their protein and water contents. 
Later, it was discovered that the CLA trans10, cis12 
isomer could be responsible for those effects (Wahle 
et al., 2004; Park and Pariza, 2007). The ability of 
CLA to influence lipid metabolism has been attrib-
uted to some factors such as increase in lipolysis 
and fatty acid oxidation rate and reduction in cel-
lular fatty acid absorption (Park and Pariza, 2007). 
Gilbert et al., (2011) found that trans–trans CLA-
rich soy oil lowered liver lipids and reduced serum 
cholesterol and low-density lipoprotein cholesterol 
by 41 and 50%, respectively, compared to obese rats.
Conjugated linolenic acids are a group of geo-
metric and conformational isomers of linolenic 
acid in which double links are in conjugate forms. 
CLnA isomers could be found as the major fatty 
acid in the oils extracted from the special plant 
seeds; α-eleostearic acid (cis9, trans11, trans13-18:3) 
in bitter gourd, punicic acid (cis9, trans11, cis13-
18:3) in pomegranate, catalpic acid (trans9, trans11, 
cis13-18:3) in catalpa and jacaric acid (cis8, trans10, 
cis12-18:3) in jacaranda seed oils (Mine et al., 2009). 
Arao et al., (2004) fed the rats with a diet enriched 
with pomegranate seed oil (PSO) and reported that 
punicic acid significantly reduced the accumulation 
of triacylglycerols (TAG) and monounsaturated 
fatty acids in the liver. They reported that PSO, 
thanks to its high phyto-estrogen content, could 
prevent breast cancer and be used in dermatological 
anti-aging products. Yuan et al., (2009) found that 
CLnA and CLA could exhibit distinctive effects on 
body fat mass and liver triacylglycerol levels in mice. 
They reported that the TAG level in the liver was 
significantly decreased in mice fed with punicic 
acid while this value significantly increased in ani-
mals fed with the CLA isomer mixture. Koba et al., 
(2002) compared the effect of dietary CLnA on 
body weight, serum and liver lipid levels with that 
of CLA in rats. They observed that CLnA but not 
CLA significantly increased serum and liver TAG 
concentrations. 
The properties and healthful impacts of oils and 
fats are directly related to the type of triacylglycer-
ols. Nevertheless, the triacylglycerol type is charac-
terized by the type and location of fatty acids within 
the glycerol molecular structure (Reena et al., 2009; 
Farmani and Hamedi, 2006). Translocation of 
fatty acids within TAG can occur through a pro-
cess called interesterification. A structured lipid 
(SL) is a TAG in which new fatty acids have been 
attached or have been re-structured so that the fatty 
acid location is changed and a new triacylglycerol 
structure would be synthesized (Lee and Lee, 2006). 
Interesterification could be applied as an approach 
to incorporate functional lipid components such as 
CLA or CLnA in a TAG backbone and consequently 
increase their concentration in edible fats and oils. 
CLA was successfully incorporated into canola oil 
through acidolysis as its content in produced SL was 
26.6 mol% after 48 h of reaction time (Goli et al., 
2008). Adhikari et al., also produced an interesteri-
fied fat containing 5.2–6.1% CLA using soybean 
oil and palm stearin as base stocks (Adhikari et al., 
2012). In order to elevate the healthful effects of 
oils and fats, the concept of changing TAG struc-
ture and balancing the type of fatty acids has been 
recently advocated by nutritionists, dieticians and 
medical practitioners (Reena et al., 2009).
In order to obtain the health benefits of CLA and 
CLnA simultaneously, it is imperative and desirable 
to produce specific structured lipids (SLs) includ-
ing both functional fatty acids in TAG structure. 
Therefore, the aim of this work was to synthesize 
a novel SL comprising of CLA and CLnA through 
enzymatic interesterification and attest its health-
promoting effects on the serum and liver lipids of 
Wistar rats.
2. MATERIALS AND METHODS
2.1. Materials
CLA oil, as a triacylglycerol molecule, containing 
73.5% conjugated linoleic acid was kindly donated 
by Nutrition Lipid Co. (Wormerveer, Netherlands). 
Pomegranate seed was obtained from Neyriz Co. 
(Shiraz, Iran). The rhizomucor miehei lipase enzyme 
(RM IM) was a gift provided by Novozymes (Tehran, 
Iran). Wistar rats were obtained from Razi Research 
Institute (Tehran, Iran) and their prepared powdered 
food was purchased from Pars Animal Feed Co. 
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(Tehran, Iran). The standard diet contained crude 
fat 2%, crude protein 17.5%, crude fiber 6.6%, min-
eral mixture 3.5% and vitamin mixture 1%. Serum 
cholesterol, triacylglycerols, low-density lipoprotein 
cholesterol (LDL-C) and high-density lipoprotein 
cholesterol (HDL-C) were measured on a Hitachi 
902 biochemistry analyzer by commercial colori-
metric kits from Pars Azmoon Co. (Tehran, Iran). 
Pure methyl esters of fatty acids (99.9% purity) as 
standards including palmitic (16:0), stearic (18:0), 
oleic (18:1), linoleic (18:2), isomers of conjugated 
linoleic (cis9, trans11 and trans10, cis12-18:2) and 
conjugated linolenic acids (cis9, trans11, cis13-18:3, 
punicic acid) were purchased from Sigma-Aldrich 
Chemical Co. (St Louis, MO). Triacylglycerol stan-
dards (≥ 99% purity) including LnLnLn (Ln: lino-
lenic acid), LLL (L: linoleic acid), OOO (O: oleic 
acid), PPP (P: palmitic acid) and SSS (S: stearic 
acid) were obtained from Sigma-Aldrich Chemical 
Co. (St Louis, MO). Other triacylglycerols present 
in the samples were identified by Equivalent Carbon 
Number. 
2.2. Structured lipid production
Pomegranate seed oil was firstly extracted from 
pomegranate seeds using the solvent extraction 
method according to Abbasi et al., (2008) with some 
modification. The seeds were ground, immersed in 
n-hexane (1:2, w/v) and mixed for 6 h under vacuum 
atmosphere. Finally, the extract was filtered to 
remove solid particles and the solvent was elimi-
nated using a rotary vacuum evaporator. The oil 
was kept in amber bottles at refrigerator tempera-
ture until further analysis. 
In order to produce structured lipids including 
CLA and CLnA, CLA oil was enzymatically inter-
esterified with PSO, as a good source of CLnA, 
using the microbial lipase enzyme, RM IM lipase. 
To investigate the effect of the main parameter and 
optimize the process, the response surface method-
ology (RSM) was applied. The numeric factors at 
three levels consisted of reaction time in the range 
of 24-72 h, reaction temperature in the range of 
45-65 °C and CLA content in the range of 40-60% 
were attested. The ratio of CLA/CLnA and free 
fatty acid content in the structured lipid were con-
sidered as responses (Table 1). Free fatty acid con-
tent was measured based on the AOCS method 
Cd 3d-63 (AOCS 2004). The ratio CLA/CLnA 
was determined by the quantification of CLA and 
CLnA in each treatment using gas chromatography 
as described in section 2.3.
Based on the minimum content of FFA (2.3%) 
and nearly equal contents of CLA and CLnA (1:1) 
in the structured lipid (SL), the optimized conditions 
of weight ratio (CLA oil to PSO), reaction time and 
temperature were selected as 43%, 24 h and 56 °C, 
respectively using RSM. In these optimized points, 
the reaction yield for TAG synthesis was 97.7%. 
Table 1. Treatments conducted based on RSM and obtained values for ratio of CLA:CLnA and 
free fatty acid (FFA) percentage in the products.
Treatments (Run)
Time
(h)
Temperature
(oC)
CLA
(% substrate) CLA:CLnA %FFA
1 24 45 40 1.28 2.38
2 48 50 45 0.86 2.08
3 24 65 40 1.93 2.62
4 72 45 60 1.05 2.15
5 72 65 60 0.8 2.75
6 72 65 40 1.54 2.5
7 48 55 60 1.91 2.77
8 72 55 50 1.84 2.58
9 24 65 60 1.88 2.42
10 24 45 60 0.85 2.51
11 24 55 40 0.89 2.09
12 24 45 50 0.9 2.33
13 72 45 60 1.77 2.24
14 72 45 40 1.87 1.59
15 72 65 40 1.93 2.49
16 24 65 60 0.84 2.23
17 48 65 50 1.92 2.8
18 72 65 60 1.9 2.72
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Accordingly, the reaction was performed to produce 
enough SL for further experiments. Conjugated lin-
oleic acid oil and PSO as an enzyme substrate (43:57 
w/w) were weighed in a 250 mL Erlenmeyer flask 
with a screw cap. The reaction was started by add-
ing the microbial lipase enzyme (7% by total weight 
of substrate). The flask containing the reaction mix-
ture (CLA oil, PSO and lipase) was flushed by nitro-
gen, sealed with a stopper and incubated for 24 h in 
an orbital shaker at 200 rpm and 56 °C.
2.3. Fatty acids profile of CLA, pomegranate seed 
and SL oils
The fatty acids profile of the oils was determined 
by gas chromatography (Agilent, Model 6890 n, 
USA) following their methyl ester preparation using 
the method described by Goli et al., (2008). Briefly, 
a 50 micro liter sample was dissolved in 1 milliliter 
of hexane, then 100 micro liters sodium methoxide 
(0.5  N) were added and the mixture was shaken 
at room temperature for 15 min. At the end, the 
methylated sample was passed through anhydrous 
sodium sulfate to lose its moisture. A HP-88 column 
(100 m × 250 µm × 0.20 µm) was used to separate 
fatty acid methyl esters. The carrier gas was nitrogen 
with a flow rate of 1.1 ml/min. The column tempera-
ture program was first held for one minute at 150 ºC, 
then increased to 190 ºC at a rate of 5 ºC/min, after 2 
min at 190 ºC, the temperature was raised to 240 ºC 
at a rate of 5 ºC/min, and kept at this temperature 
for 8 min. The detector was flame ionization detec-
tor (FID) and the temperatures of the detector and 
injector were 250 ºC and 150 ºC, respectively. The 
injection volume was one micro liter with a 1 to 30 
split ratio.
2.4. Triacylglycerol structure in CLA, pomegranate 
seed and SL oils
Reverse-phase high pressure liquid chromatog-
raphy (HPLC- Younglin, Germany) was used to 
determine the TAG species of pomegranate seed, 
CLA and SL oils. The HPLC system consisted of 
a dual pump (SP930D; Yonglin Anyang, Korea) 
with evaporative light-scattering detector (ELSD, 
Sedex 75; Sedere, Alfortville, France). The nebuliz-
ing gas was nitrogen set at 2.2 bar, the evaporation 
temperature was set at 40 ºC and the gain (PM) at 
11. For separation, a Nova-Pak C18 column (150 
mm × 3.9 mm × 4 µm, Waters, Milford, MA, USA) 
was used. The column temperature was 25 ºC. The 
elution solvent consisted of (A) acetonitrile and (B) 
isopropanol/hexane (2:1, v/v). The mobile phase 
flow rate of 1 ml/ min was selected with the follow-
ing profiles; 0-44 min, 20% B; 45-50 min, 46% B; 
51-58 min, 100% B. Each sample (5 mg) was first fil-
tered, followed by dissolving in chloroform (10 ml) 
and then 20 µL were injected into the HPLC. Peak 
determination was made in comparison to the reten-
tion time of TAG standards and the calculation of 
Equivalent Carbon Number (ECN) (Mitra et al., 
2010).
2.5. Animals
Forty male Wistar rats, weighing about 177-227 
grams and 5-weeks-old at the beginning of the exper-
iment, were housed in aluminum cages (five rats in 
each cage) with filter tops under controlled condi-
tions of 12-hour light/dark cycle, 50±5% humidity 
and 23±2 ºC temperature. The Ethics Committee 
of the Isfahan Cardiovascular Research Center 
approved the present study, and the animals were 
handled according to the guidelines of the Isfahan 
University of Medical Sciences (Isfahan, Iran) for 
the care and use of laboratory animals.
2.6. Experimental design
After a 7-day adaptation period, the rats were 
randomly divided into four groups, ten animals in 
each and weighed as initial weight. Food (standard 
pellet) and water were provided ad libitum. The rats 
were given 1500 mg/ kg body weight per day via oral 
gavage for 45 days as follows: group 1, pomegranate 
seed oil; group 2, CLA oil; group 3, structured lipids 
and group 4, soybean oil (as a control group).
2.7. Blood sample collection and analysis
In order to evaluate the blood factors, blood col-
lection was done two times; on day zero and at the 
end of treatment period (on the 45th day). The rats 
were fasted for 16 hours before sampling. The blood 
collection was performed by cardiac puncture under 
anesthesia (diethyl ether). The serum was separated 
by centrifuge (at 2500 × g for 20 min) and analyzed 
for total cholesterol, triacylglycerol, low density 
lipoprotein cholesterol (LDL-C) and high density 
lipoprotein cholesterol (HDL-C) using biochemical 
test Pars Azmoon Kits (Pars Azmoon Co., Tehran) 
according to the colorimetric method.
2.8. Liver lipid extraction
At the end of the experimental period, the liver 
of the rats was dissected, weighed, immediately fro-
zen and stored at -20 ˚C until analysis. Total lipid 
was extracted by the method of Folch et al., (1975). 
Briefly, one gram of homogenized liver was added 
to a 2:1 solution of chloroform/methanol (v/v). The 
final volume was 20 ml and it was thoroughly mixed 
for 20 min. After filtration, distilled water (4 ml) was 
added to the mixture and centrifuged. The lower 
phase was isolated and the lipid was obtained by 
evaporating the solvent. Commercial biochemical 
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kits were used to measure the concentration of cho-
lesterol and TAG in liver.
2.9. Statistical analysis
All experiments were carried out in triplicate 
(n = 3) and reported as the mean ± SD. The data 
were statistically analyzed by ANOVA program in 
statistix 8 software. The means test was conducted 
using the least significant difference (LSD) test at a 
confidence level of 95%. To evaluate significant dif-
ferences between the values obtained from days zero 
and 45, the t-student’s test was applied.
3. RESULTS
3.1.  Fatty acid composition and triacylglycerol 
structure
The Fatty acids profile of the oils is shown in 
Table 2. CLA oil contained nearly equal values 
of the two major isomers of CLA; cis9, trans11 
(36.8%) and trans10, cis12 (38.5%). The predomi-
nant fatty acid in PSO was conjugated linolenic acid 
(cis9, trans11, cis13-18:3, CLnA), which is known 
as punicic acid (77.1%), followed by linoleic (7.9%) 
and oleic (7%) acids. 
After interesterification and in the structured 
lipid, the major fatty acids were found to be CLnA 
(39.5%) followed by cis9, trans11 (19.4%) and 
trans10, and cis12 (19.1%) CLA isomers. With 
respect to fresh oils, the fatty acid composition 
changed in SL after lipase-catalyzed interesterifica-
tion. The major fatty acids in PSO, namely punicic 
and linoleic acids decreased to about 39.5 and 4.7% 
respectively, while the CLA content reached 38.5% 
in SL. The result showed that the interesterification 
reaction was well successful to produce a SL con-
taining almost equal amounts of CLA (38.5%) and 
CLnA (39.5%). Generally, it could be said that the 
produced SL consisted of 78% fatty acids of CLA 
and CLnA.
The result of the interesterification reaction was 
also monitored by following the changes in the rela-
tive concentrations in the various TAG species of 
PSO and CLA oil (Table 3). Originally, PSO con-
tained two major TAGs of CnCnCn (58.5%) and 
Table 2. Fatty acid compositions (g/100 g total fatty acids) of CLA oil, pomegranate seed oil, structured lipid and soybean oil.
Fatty acids CLA oil Pomegranate seed oil Structured lipid Soybean oil 
16:0 5.0±0.01 3.8±0.05 3.7±0.01 11.3±0.03
18:0 2.0±0.00 2.3±0.00 1.8±0.04 4.4±0.00
18:1 c9 11.0±0.06 7.0±0.09 10.6±1.01 23.1±0.11
18:2 c9, c12 1.1±0.01 7.9±0.14 4.7±0.07 52.9±1.22
18:3 c9, c12, c15 - - - 5.6±0.08
c9, t11, c13 CLnA - 77.1±0.22 39.5±1.51 -
c9, t11 CLA 36.8±0.08 - 19.4±0.02 -
t10, c12 CLA 38.5±0.10 - 19.1±0.00 -
Total CLA 75.3±0.18 - 38.5±0.02 -
others 5.6±0.03 1.9±0.02 1.2±0.01 2.6±0.01
CLA, Conjugated linoleic acid; CLnA, Conjugated linolenic acid
Mean value ± standard deviation (n = 3)
The means test was done using least significant difference (LSD) test at a confidence level of 95%.
Table 3. Triacylglycerol compositions (g/ 100 g 
triacylglycerols) of pomegranate seed oil, CLA oil and 
structured lipid.
TAG
Pomegranate 
seed oil CLA oil
Structured 
lipid
CnCnCn 58.5±0.15 1.5±0.00 12.9±0.15
CnCnL 9.9±0.05 - -
CnCnLc - - 27.3±0.09
CnCnO 17.6±0.13 - -
CnLcLc - 1.1±0.01 27.9±0.14
CnLO 7.7±0.08 - -
LcLcLc - 54.3±0.17 18.3±0.11
LcLcO - 30.6±0.24 8.8±0.06
LLO 2.5±0.01 - -
LOO - 8.1±0.10 3.1±0.01
OOO - 2.1±0.03 1.0±0.00
Lc: conjugated linoleic acid; Cn: conjugated linolenic acid; O: 
oleic acid; L: linoleic acid
Mean value ± standard deviation (n = 3)
The means test was done using least significant difference (LSD) 
test at a confidence level of 95%.
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CnCnO (17.6%); whereas in CLA oil, LcLcLc 
(54.3%) and LcLcO (30.6%) were the abundant 
TAGs (Cn: conjugated linolenic acid, Lc: conju-
gated linoleic acid, O: Oleic acid,). The TAG type 
of oil is directly dependent on its fatty acid com-
position. Since the major fatty acids in PSO and 
CLA oil were CLnA and CLA, the predominant 
TAG was the homogenous TAG of CnCnCn and 
LcLcLc, respectively. Interesterification is a power-
ful tool for changing the quantity of existing triac-
ylglycerol molecules and/or the emergence of new 
triacylglycerol molecules. After the reaction, lipase 
enzyme transferred fatty acids between the TAGs of 
PSO and CLA oil and led to a significant reduction 
in the homogenous TAGs of CnCnCn (from 58.5 to 
12.9%) and LcLcLc (from 54.3 to 18.3%), respec-
tively (Table 3). On the contrary, heterogeneous TAG 
containing mixtures of Cn and Lc such as CnLcLc 
(27.9%) and CnCnLc (27.3%) were increased in SL. 
The structured lipid consisted of four major TAGs 
of CnLcLc, CnCnLc, LcLcLc and CnCnCn, which 
showed that the interesterification condition was 
suitable to produce a new oil containing CLA and 
CLnA in its TAG structure.
3.2. Biochemical effects of structured lipid, 
pomegranate seed and CLA oils
Body weight and food intake. The effect of  dif-
ferent diets supplemented with CLA oil, PSO, SL 
and also soy bean oil on body weight gain of  rats 
after 45 days is presented in Figure 1. A significant 
(p < 0.05) increment was observed in all groups 
for final weight of  rats compared to the begin-
ning of  the experiment period. Although the final 
weight of  the rats fed with CLA and SL was higher 
than that of  PSO and soybean oil, there was no 
significant difference among the four treatments 
regarding final weight or weight gain of  rats. The 
lowest and highest amount of  food intake was 
administrated by the PSO and SL groups (15.13 
and 15.30 g/d, respectively) even though they did 
not show any significant difference compared to 
other groups. 
Serum lipid levels. The effects of the various oils 
fed to the rats on their blood serum composition 
are shown in Table 4. In terms of HDL-C, only the 
CLA and soybean oil groups showed significant (p < 
0.05) increments after 45 days (ca. 20% increase in 
both groups). However, there was no significant dif-
ference in the HDL-C levels of the different groups 
of rats compared to the soybean oil group on the 
45th day of the experimental period. 
The concentration of serum LDL-C in the rats 
fed pomegranate seed oil declined significantly (p < 
0.05) from 0.45 to 0.27 mmol/l after 45 days. As can 
be seen in Table 4, the type of supplemented lipid 
had no significant effect on serum LDL-C in Wistar 
rats. 
A significant (p < 0.05) reduction (about 24%) in 
total cholesterol (TC) was found in the PSO group 
over 45 days (Table 4). At the end of the experi-
mental period, there was no significant difference 
in TC between the treated rats in each group and 
the soybean oil group. The results of serum HDL-C, 
LDL-C and TC revealed that PSO was able to reduce 
total cholesterol without lowering the HDL-C level 
in rats.
According to Table 4, serum triacylglycerol 
(TAG) content in all treated rats as well as the soy-
bean oil group decreased remarkably. The results of 
TAG level on 45th day showed that this parameter 
was unchanged in the animals fed CLA oil, PSO 
and SL compared to the soybean oil group.
Figure 1. Body weight changes of Wistar rats fed with different 
dietary lipids for 45 days (n = 10).
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Liver lipid levels. Table 4 shows the liver lipid, tri-
acylglycerol and cholesterol contents of Wistar rats. 
The experiments showed that SL, containing nearly 
the same content of CLA and CLnA, had the most 
significant effect on the reduction of lipid content 
(from 8.71 to 4.65%) and TAG (from 18.83 to 13.2 
mg/g) of liver compared to soybean oil. It might be 
affirmed that the novel SL could decrease the accu-
mulation of lipids in the liver. Pomegranate seed oil 
had no significant effect on liver triacylglycerol in 
rats compared to the soybean oil sample. Although 
PSO could reduce the weight of liver lipids signifi-
cantly (p < 0.05), it was not as effective as the struc-
tured lipid. Moreover, in comparison to soybean oil, 
the liver lipid weight and TAG content increased in 
the rats fed the CLA oil (5.5% and 30.4% increment, 
respectively).
4. DISCUSSION
To the best of our knowledge, this is the first work 
to investigate the effect of a novel structured lipid 
(consisting of equal amounts of CLA and CLnA) 
on serum and liver lipid characteristics in a healthy 
animal model- Wistar rat. 
Our findings on the fatty acid profile of PSO 
were in agreement with the results obtained by other 
researchers who demonstrated that the CLnA level 
of PSO in 25 pomegranate varieties grown in Iran 
was in a wide range from 31.8 to 86.6% (Fadavi et al., 
2006). In another report, the amount of punicic acid 
was reported at about 72% Punica granatum seed oil 
(Miranda et al., 2009). According to Turtygin et al., 
(2013) the seed oil from various pomegranates con-
tained a wide range of punicic acid from 70.24 to 
89.68%.
 In this study, CLA oil, PSO and SL had no sig-
nificant effect on the body weight of rats compared 
to the control. This result was in concordance with 
the report showing that adding 1% punicic acid and 
1% CLA into the mice diet had no significant effect 
on final body weight (Miranda et al., 2009). It has 
been reported that there was no remarkable differ-
ence among the final weight of Wistar rats fed with 
0.5% CLA, 0.5% CLnA and the control group over 
7 weeks (Miranda et al., 2009). Moreover, the feed 
supplemented with pomegranate seed oil (0.12 and 
1.2%) showed no effect on the body weight of mice 
for 3 weeks (Yamasaki et al., 2006). According to 
Vyas et al., (2012) and Kostogrys and Pisulewski 
(2010), a diet containing conjugated linoleic acid 
had no effect on the body weight of rats. Koba et al., 
(2002) found that the groups fed with 1% of experi-
mental fats; CLA, CLnA, linoleic acid and linolenic 
Table 4. Serum and liver lipids in Wistar rats fed with different dietary lipids for 45 days.
Parameters
Treatment groups
CLA oil Pomegranate seed oil Structured lipid Soybean oil 
Serum lipids
HDL-C (mmol/l)
Day zero 0.95±0.09b 1.18±0.22 1.06±0.16 0.92±0.25b
Day 45 1.14±0.13a 1.10±0.13 1.19±0.15 1.10±0.17a
LDL-C (mmol/l)
Day zero 0.39±0.18 0.45±0.19a 0.34±0.26 0.27±0.13
Day 45 0.28±0.05 0.27±0.05b 0.30±0.08 0.29±0.07
Total cholesterol (mmol/l)
Day zero 1.93±0.22 2.30±0.22a 2.00±0.46 1.83±0.19
Day 45 1.82±0.24 1.74±0.20b 1.92±0.30 1.80±0.30
Triacylglycerol (mmol/l)
Day zero 1.90±1.40a 1.40±0.40a 1.64±0.58a 1.68±0.57a
Day 45 0.69±0.25b 0.62±0.16b 0.77±0.21b 0.83±0.23b
Liver lipids
Liver lipid weight (g/100g of liver) 9.19±0.35A 6.36±0.18C 4.65±0.19D 8.71±1.25B
Liver triacylglycerol (mg/g) 24.57±0.97A 18.51±1.20B 13.28±0.68C 18.83±1.10B
Liver cholesterol (mg/g) 10.15±1.21 8.76±1.84 8.64±2.51 8.46±1.60
Mean value ± standard deviation (n = 10), The means test was done using least significant difference (LSD) test at a confidence level of 
95%. The t-student’s test was applied to evaluate significant differences between the values obtained from zero and day 45. 
CLA: Conjugated linolenic acid; HDL-C: High density lipoprotein cholesterol; LDL-C: Low density lipoprotein cholesterol
Means followed by different small letters within a column for each parameter are significantly different (P < 0.05)
Means followed by different capital letters within a row are significantly different (P < 0.05)
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acid showed no significant difference in final body 
weight after 4 weeks. On the contrary, a significant 
reduction in body weight of Otsuka-Long Evans 
Tokushima (OLETF) rats fed 5% punicic acid (cis9, 
trans11, cis13), not 2% was observed after 2 weeks 
by Arao et al., (2004). 
Many epidemiological studies have reported the 
importance of abnormalities in LDL-C, triacylglyc-
erol, total cholesterol and even HDL-C as risk fac-
tors for cardiovascular disease. High levels of serum 
cholesterol, especially the low density type known 
as LDL-C, are considered major risk factors for 
coronary heart disease (CHD); whereas high levels 
of the high density type (HDL-C) are recognized as 
beneficial in reducing CHD risk (Parto et al., 2015). 
According to our results, blood serum parameters 
(HDL-C, LDL-C, TC and TAG) were not affected 
by CLA oil, PSO or SL given as an oral gavage after 
45 days. In terms of total cholesterol, the data was 
consistent with the results reported by Yuan et al., 
(2009). It has been reported that the concentration 
of serum cholesterol was significantly lower in the 
CLnA than in the linoleic acid group in rats (Koba 
et al., 2002). In another research, it was found that 
margarine supplemented with 0.5% CLnA and 0.5% 
CLA had no significant effect on the TC of mice 
after short (10 week) and long (18 week) periods of 
feeding (Franczyk-Zarów et al., 2015). Koba et al., 
(2002) also demonstrated how 1% CLA exhibited a 
decreasing trend, although this cholesterol-lowering 
effect was not statistically significant against 1% lin-
oleic acid. Interestingly, it has been reported that the 
total serum cholesterol of rats fed with 2.4% punicic 
acid was the lowest compared to the highest value 
obtained with a 1.2% punicic acid diet (Mukherjee 
et al., 2002). 
Our findings on HDL-C were in agreement with 
the results of Yuan et al., (2009) who did not find 
any effect of supplementation with 1% punicic acid 
for 6 weeks on serum HDL-C in mice. Moreover, 
this author showed that feeding diets supplemented 
with 1% purified punicic acid did not exhibit a sig-
nificant effect on HDL-C in hamsters. Furthermore, 
it was reported that margarine supplemented with 
0.5% punicic acid (cis9, trans11, cis13-18:3), 0.5% 
CLA and linolenic acid had no effect on HDL-C 
serum in apoE/LDLR-/- mice after short (10 weeks) 
and long (18 weeks) periods (Franczyk-Zarów et al., 
2015). 
With respect to LDL-C, Mukherjee et al., [24] 
reported that the diet containing 0.6 (59.5 mg.dl-1) 
and 2.4% (56.5 mg.dl-1) punicic acid could signifi-
cantly lower LDL-C while the rats fed with 1.2% 
punicic acid showed a higher level of LDL-C (100.1 
mg.dl-1) compared to the control (66.5 mg.dl-1). In 
agreement with our work, another researcher found 
that dietary CLA treatments had no significant 
effects on the TC, HDL-C and LDL-C in Wistar 
rats (Kostogrys and Pisulewski, 2010).
Similar results for serum triacylglycerol were also 
reported by other researchers (Mukherjee et al., 
2002; Kostogrys and Pisulewski, 2010) who found 
TAG was decreased in rats fed CLA-supplemented 
diet. However, Yuan et al., (2009) obtained no sig-
nificant differences in TAG, TC, HDL-C or LDL-C 
levels in serum among the groups fed with corn oil 
(as control), punicic acid and CLA. These results 
are in good accordance with the study showing that 
there was not any remarkable effect on TAG, TC, 
HDL-C serum in mice fed with CLnA, CLA and 
linoleic acid compared to control group after 10 
weeks. On the contrary, Koba et al., (2002) observed 
that the concentration of serum TAG increased 2.5-
fold in rats fed CLnA compared to the animals fed 
linoleic acid, linolenic acid or CLA.
Liver is the central organ responsible for triglyc-
eride and cholesterol metabolisms and plays a key 
role in many physiological and patho-physiological 
states involving lipid metabolism. Since lipid metab-
olism in liver dictates the crucial steps in atheroscle-
rosis, non-alcoholic fatty liver disease (NAFLD), 
diabetes, MS, insulin sensitivity, lipotoxicity and 
many other systemic diseases, monitoring the 
changes in liver lipids is important (Hassan et  al., 
2014). Regarding liver lipids, SL had the greatest 
effects on reduction in its weight and triacylglycer-
ols and the maximum amount of these parameters 
belonged to the rats fed with CLA oil. PSO could 
reduce the amount of mentioned values in Wistar 
rats compared to soybean oil after 45 days. Similar 
results have been reported by other researchers 
(Arao et al., 2004; Koba et al., 2007), who found that 
the levels of liver TAG decreased by feeding a diet 
supplemented with 9% safflower oil and 1% PSO in 
Otsuka-Long Evans Tokushima (OLETF) rats for 2 
weeks and a diet with pomegranate seed oil in ICR 
CD1 mice for 4 weeks, respectively. However, Koba 
et al., (2002) reported that CLnA increased liver 
TAG concentration two-fold compared to linoleic 
acid, linolenic acid and conjugated linoleic acid. 
Previous studies on mice showed that CLA could 
cause significant hepatomegaly accompanied by an 
accumulation of lipids in the liver (Yuan et al., 2009; 
Wendel et al., 2008). The obtained findings in the 
present work (difference among the groups) could 
be mainly attributed to the fatty acid composition 
of used lipids. CLA oil with 75.3% isomers of cis9, 
trans11 and trans10, cis12 accumulated lipid and tri-
acylglycerol in the liver while PSO containing 77.1% 
punicic acid (CLnA) significantly reduced liver lipid 
and TAG. However, SL, consisting of 38.5% CLA 
and 39.5% CLnA, had a significant reductive effect 
on lipid and TAG levels of liver which might prove 
that the combination of both CLA and CLnA oils in 
one lipid could have a synergistic effect for reducing 
the lipid and TAG levels of liver. It is possible, how-
ever, that high concentrations of CLnA and CLA 
had a negative impact on liver TAG. No significant 
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difference in liver cholesterol level was obtained 
among the four groups, which is consistent with the 
results of other papers (Yuan et al., 2009; Kostogrys 
and Pisulewski, 2010).
5. CONCLUSIONS
The aim of the present study was to investigate 
the positive effects of both conjugated linolenic 
and conjugated linoleic acid in a novel structured 
lipid (SL) on blood serum and liver lipids in healthy 
Wistar rats. The lipid had a potent effect mainly on 
reducing liver lipid and triacylglycerol compared to 
the other fed lipids. Moreover, the structured lipid 
showed a minimum total cholesterol concentration 
in liver. The findings revealed that SL could be con-
sidered as a healthful lipid specifically on liver lipid 
composition and be useful for patients with non-
alcoholic fatty liver disease (NAFLID), although 
pharmacokinetic tests on its absorption, toxicity and 
optimal dose are necessary. It is worth noting that 
further research is needed to examine the effect of 
this lipid on the blood serum along with some ben-
eficial and supplementary analysis such as RT-PCR, 
FASN, SREBP1c, SCD1, PPARs and western blot 
technique to confirm the data. Moreover, safety 
concerns regarding the use of SL in humans would 
need further investigation with a better experimen-
tal designs that will clarify the mechanisms of SL’s 
activities.
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